Tabassom Mohajer Shojai
Doktorand vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerprecisionsmedicin; Forskargrupp Marika Nestor
- E-post:
- tabassom.mohajer@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Publikationer
Senaste publikationer
-
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 768-778, 2024
- DOI för p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
- Ladda ner fulltext (pdf) av p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
-
Enhancing Cancer Treatment through Combination Therapies
2024
-
Ingår i Cancers, 2023
- DOI för Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
- Ladda ner fulltext (pdf) av Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
-
Photoactive immunoconjugates for targeted photodynamic therapy of cancer
Ingår i Journal of Photochemistry and Photobiology. B, 2023
-
Ingår i Frontiers in Oncology, 2022
- DOI för In Vitro Characterization of Lu-177-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer
- Ladda ner fulltext (pdf) av In Vitro Characterization of Lu-177-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer
Alla publikationer
Artiklar i tidskrift
-
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 768-778, 2024
- DOI för p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
- Ladda ner fulltext (pdf) av p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
-
Ingår i Cancers, 2023
- DOI för Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
- Ladda ner fulltext (pdf) av Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
-
Photoactive immunoconjugates for targeted photodynamic therapy of cancer
Ingår i Journal of Photochemistry and Photobiology. B, 2023
-
Ingår i Frontiers in Oncology, 2022
- DOI för In Vitro Characterization of Lu-177-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer
- Ladda ner fulltext (pdf) av In Vitro Characterization of Lu-177-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer
-
Ingår i Frontiers in Oncology, 2020
- DOI för Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib
- Ladda ner fulltext (pdf) av Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib